Preferred Label : benserazide;
MeSH definition : An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system.
It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion
of levodopa to dopamine in the periphery, thereby increasing the amount that reaches
the central nervous system and reducing the required dose. It has no antiparkinson
actions when given alone.;
MeSH synonym : seryltrihydroxybenzylhydrazine; benzylhydrazine, seryltrihydroxy; dl-serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide; seryltrihydroxy benzylhydrazine; serazide;
MeSH hyponym : ro 4-4602; Ro 4 4602; Ro 44602;
MeSH CAS label : DL-Serine, 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide;
MeSH Related Number : 322-35-0 (Benserazide);
Registry Number MeSH : 322-35-0;
Is substance : O;
UNII : 762OS3ZEJU;
InChIKey : BNQDCRGUHNALGH-UHFFFAOYSA-N;
Origin ID : D001545;
UMLS CUI : C0005014;
Allowable qualifiers
Manual BTNT mappings - CISMeF
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
See also inter- (CISMeF)
Semantic type(s)
Validated automatic mappings to BTNT
An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system.
It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion
of levodopa to dopamine in the periphery, thereby increasing the amount that reaches
the central nervous system and reducing the required dose. It has no antiparkinson
actions when given alone.
http://www.has-sante.fr/portail/jcms/c_2678868/fr/modopar
http://www.has-sante.fr/portail/jcms/c_461094/fr/modopar
2016
false
France
French
treatment outcome
Benserazide Hydrochloride
drug combinations
levodopa
dopa decarboxylase
antiparkinson agents
dopamine agents
benserazide
benserazide, levodopa drug combination
enzyme inhibitors
administration, oral
levodopa and decarboxylase inhibitor
insurance, health, reimbursement
parkinson disease
parkinsonian disorders
evaluation of the transparency committee
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64786092
2012
France
summary of product characteristics
package leaflet
capsules
benserazide, levodopa drug combination
benserazide
levodopa
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60793381
2012
France
summary of product characteristics
package leaflet
benserazide
levodopa
benserazide, levodopa drug combination
capsules
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60660790
2012
France
summary of product characteristics
package leaflet
capsules
levodopa
benserazide, levodopa drug combination
benserazide
---